Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Refolo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|October 20, 2015
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCCRosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, et al.
Anticancer Research|October 15, 2010
Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesisMichele Linsalata, Antonella Orlando, Caterina Messa, et al.
Cancers|March 14, 2020
Inflammatory Mechanisms of HCC DevelopmentMaria Grazia Refolo, Caterina Messa, Vito Guerra, et al.
Journal of Leukocyte Biology|March 15, 2020
Integrated immune gene expression signature and molecular classification in gastric cancer: New insightsMaria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, et al.
Scientific Reports|April 30, 2020
Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell linesMaria Grazia Refolo, Claudio Lotesoriere, Ivan Roberto Lolli, et al.
International Journal of Molecular Sciences|May 23, 2018
Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma CellsMaria Grazia Refolo, Catia Lippolis, Nicola Carella, et al.
International Journal of Molecular Sciences|February 27, 2026
RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 1518Maria Grazia Refolo, Catia Lippolis, Nicola Carella, et al.
Cancer Chemotherapy and Pharmacology|April 25, 2015
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factorRosalba D'Alessandro, Maria Grazia Refolo, Catia Lippolis, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 3, 2015
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1Catia Lippolis, Maria Grazia Refolo, Rosalba D'Alessandro, et al.
Cancers|June 12, 2019
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and MotilityRosalba D'Alessandro, Maria Grazia Refolo, Palma Aurelia Iacovazzi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|October 20, 2015
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCCRosalba D'Alessandro, Caterina Messa, Maria Grazia Refolo, et al.
Anticancer Research|October 15, 2010
Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesisMichele Linsalata, Antonella Orlando, Caterina Messa, et al.
Cancers|March 14, 2020
Inflammatory Mechanisms of HCC DevelopmentMaria Grazia Refolo, Caterina Messa, Vito Guerra, et al.
Journal of Leukocyte Biology|March 15, 2020
Integrated immune gene expression signature and molecular classification in gastric cancer: New insightsMaria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, et al.
Scientific Reports|April 30, 2020
Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell linesMaria Grazia Refolo, Claudio Lotesoriere, Ivan Roberto Lolli, et al.
International Journal of Molecular Sciences|May 23, 2018
Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma CellsMaria Grazia Refolo, Catia Lippolis, Nicola Carella, et al.
International Journal of Molecular Sciences|February 27, 2026
RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. <i>Int. J. Mol. Sci.</i> 2018, <i>19</i>, 1518Maria Grazia Refolo, Catia Lippolis, Nicola Carella, et al.
Cancer Chemotherapy and Pharmacology|April 25, 2015
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factorRosalba D'Alessandro, Maria Grazia Refolo, Catia Lippolis, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 3, 2015
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1Catia Lippolis, Maria Grazia Refolo, Rosalba D'Alessandro, et al.
Cancers|June 12, 2019
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and MotilityRosalba D'Alessandro, Maria Grazia Refolo, Palma Aurelia Iacovazzi, et al.
Pageof 3